About the Campaign
The Campaign for Patient Access was launched by the American College of Cardiology in December 2009 as a national effort to reverse Medicare physician fee schedule cuts that threatened cardiovascular care. The site provided background on the issue, the ACC's legislative and legal response, resources for patients and practices, a newsroom tracking coverage across the country, and ways for supporters to share their stories and support the campaign.
From the Newsroom
Medicare Meltdown: Access to Health Care in "Critical Condition"
A press release warning that cardiology access was in critical condition due to Medicare payment cuts.
Read more
Cardiology Takes Legal Action Against Medicare
The ACC filed suit against HHS Secretary Kathleen Sebelius over the 2010 Physician Fee Schedule.
Read more
ACC Statement on Health Care Reform
The ACC used the State of the Union address to highlight the need to reverse the Medicare cuts.
Read more
Medicare Patients and Physicians Join Petition Drive
Patients and physicians in Washington, DC joined a petition drive calling on Congress for Medicare reform.
Read moreHow Payment Cuts Can Limit ICD Follow-Up Access in Australia
An implantable cardioverter-defibrillator (ICD) can detect dangerous heart rhythms and deliver a life-saving shock when needed. Yet implantation is only the beginning of care. Patients require regular device interrogation, battery checks, lead assessments, medication reviews and clinical decisions about whether remote alerts need an urgent response. If payments to physicians and hospitals are reduced, this continuing work can become harder to provide.
The American College of Cardiology’s Campaign for Patient Access highlighted how Medicare physician fee schedule cuts could place pressure on cardiovascular services in the United States. The same access concern matters in Australia, even though the funding system is different. Australia relies on Medicare Benefits Schedule (MBS) payments, state-funded public hospitals, private health insurance and patient contributions. When reimbursement fails to reflect the time and technical expertise involved in ICD follow-up, services may become less available, particularly outside major cities.
Why ICD Follow-Up Requires Ongoing Specialist Care
ICD follow-up is a structured clinical service rather than a quick equipment check. A cardiologist, electrophysiologist or trained cardiac physiologist may review stored rhythm episodes, therapies delivered by the device, sensing performance, battery longevity and lead impedance. The team then connects those findings with symptoms, medications, heart failure status and the patient’s wider treatment plan.
A patient who receives an inappropriate shock may need prompt assessment, reprogramming or investigation for atrial fibrillation, lead damage or another problem. A battery approaching elective replacement requires planning for a procedure, while a suspected lead fracture can require urgent intervention. These decisions depend on skilled interpretation, not simply on downloading information from a device.
Follow-up also continues for many years. People living with an ICD may attend appointments every three to six months, with additional reviews after a shock, hospital admission or change in symptoms. Remote monitoring can reduce travel and identify alerts earlier, but it still requires a clinician or specialist team to review transmissions and communicate with the patient.
How Payment Pressure Can Narrow Access
When a consultation or device review is paid below the cost of delivering it, practices may respond by shortening appointments, reducing appointment capacity or prioritising services with more sustainable funding. The impact may be gradual: longer waiting times, fewer available electrophysiology clinics and less flexibility for urgent reviews. Patients can experience these changes before a clinic formally closes.
In Australia, the effect can vary between a public cardiology service, a private specialist practice and a regional hospital. MBS rebates do not cover every cost associated with staff, equipment, software, compliance and secure data handling. Public hospitals may face separate budget pressures through state health systems, while private patients may face higher out-of-pocket expenses when specialist fees rise faster than rebates.
The risk is especially serious for people who need regular monitoring but do not appear acutely unwell. Preventive care can be undervalued because its success is measured by events that do not happen: a shock avoided, a failing lead detected early or an emergency admission prevented. If funding cuts make routine surveillance less viable, the health system may pay more later through avoidable hospital treatment.
The Access Gap Between Cities And Regional Areas
Sydney, Melbourne and Brisbane have larger concentrations of tertiary hospitals, private cardiology groups and electrophysiology specialists. Even in these cities, patients may face lengthy travel across metropolitan areas, limited appointment times and parking or public transport costs. A person who works casually or manages caring responsibilities may find repeated device reviews difficult to schedule.
The problem becomes more pronounced in regional and remote Australia. A patient in rural New South Wales, northern Queensland or Western Australia may need to travel several hours to a regional centre or fly to Perth, Adelaide or another capital city for complex device care. A local general practitioner or regional hospital can support some aspects of care, but advanced ICD programming and lead management may still depend on a specialist service elsewhere.
Telehealth and remote monitoring can help bridge distance, particularly for stable patients. However, technology does not remove every barrier. Patients need reliable internet or mobile coverage, compatible equipment, confidence using the system and a clear pathway for responding to alerts. A remote transmission is useful only when a properly staffed clinical service reviews it and acts within an appropriate timeframe.
Local Factors That Shape ICD Follow-Up
- MBS rebates, private fees and state hospital budgets can affect where follow-up is offered.
- Long-distance travel is common for patients outside Sydney, Melbourne, Brisbane, Perth and other major centres.
- Remote monitoring depends on device compatibility, telecommunications access and clinical staffing.
- Private health insurance may assist with hospital treatment but does not automatically remove specialist consultation costs.
- The Privacy Act 1988 and health-record obligations influence how device data is stored and shared.
What Reduced Follow-Up Can Mean For Patients
A cut to reimbursement does not automatically mean that every patient loses care. The danger lies in cumulative pressure. A clinic may have fewer nurses available to manage transmissions, less time for education or a narrower definition of which alerts require same-day contact. Small operational changes can increase the chance that a significant warning is delayed.
Patients may also defer appointments when out-of-pocket costs rise. Someone on a fixed income, receiving the Age Pension or managing medicines for heart failure may decide that a routine review can wait. People in regional areas face additional fuel, accommodation and lost-income costs. These expenses can make a clinically recommended appointment feel optional, even when it is an important part of preventing complications.
Missed follow-up can leave changes in battery status, lead performance or heart rhythm untreated. It may also reduce opportunities to review driving advice, medication adherence, infection symptoms and the emotional effect of shocks. Clear communication is essential: patients should know how often their device needs review, what symptoms require urgent attention and which service to contact after an alert or shock.
Warning Signs Of A Strained Follow-Up Service
- Appointments are repeatedly postponed without a clear replacement date.
- Remote transmissions remain unacknowledged or patients cannot identify who reviews them.
- Staff have less time to explain shocks, alerts, battery changes or device restrictions.
- Travel to a specialist clinic becomes the only option for a previously available local review.
- Fees rise while the appointment becomes shorter or less comprehensive.
Building A More Reliable Australian Care Pathway
A sustainable model should recognise ICD follow-up as a continuing clinical service. Funding needs to account for specialist interpretation, cardiac physiologist expertise, remote monitoring platforms, patient education and the administrative work involved in tracking alerts. Payment arrangements that focus only on face-to-face time can miss much of the care delivered between appointments.
Coordination between cardiologists, general practitioners, public hospitals and device clinics can reduce duplication. A shared care plan should identify the device type, implant date, responsible specialist service, last interrogation, battery status and escalation pathway. My Health Record may support information sharing when records are uploaded appropriately, although it does not replace direct clinical communication or a dedicated device-management system.
Australian services also need practical support for rural outreach. Visiting clinics, partnerships with regional hospitals and telehealth linked to local clinical staff can reduce unnecessary travel. The Australian Digital Health Agency’s approach to secure digital information exchange is relevant, but digital care must be designed around patients who have limited connectivity, low digital confidence or language and accessibility needs.
Funding decisions should be assessed against patient outcomes, not just immediate expenditure. A lower payment may appear to save money while increasing emergency presentations, hospital stays and travel burdens. A properly resourced follow-up service can detect problems earlier, support appropriate programming and help patients remain safely connected to their community.
Making Patient Experience Part Of The Policy Debate
Statistics can show waiting times and service volumes, but personal accounts reveal how funding decisions affect daily life. A patient in Newcastle who must take time off work for a Sydney appointment, or someone near Darwin who depends on a visiting service, can describe access barriers that may not appear in a billing dataset. Clinicians can explain how staffing limits affect alert review, education and urgent appointments.
Stories should protect privacy and avoid publishing device serial numbers, full medical records or identifying details without consent. Useful accounts can focus on the practical effect of reduced access: a delayed review, an unexpected fee, a long journey, difficulty obtaining a remote monitor or uncertainty after an ICD shock. These experiences can help professional bodies, policymakers and health services understand the value of continuity.
Patients and clinicians can also engage with local members of Parliament, state health departments, professional colleges and hospital consumer advisory groups. Evidence is strongest when it combines personal experience with specific information about delays, costs, travel distance and clinical consequences. Advocacy should support fair access while recognising that funding arrangements differ across Australian states and between public and private care.
The central message is straightforward: an ICD protects patients only when the surrounding service remains available. Payment policy, workforce planning and digital infrastructure all influence whether follow-up is timely, clinically thorough and accessible to people living beyond major metropolitan centres.
Share a de-identified account of an ICD follow-up barrier with relevant patient advocacy organisations, your cardiology service or professional representatives. Encourage decision-makers to recognise device surveillance, remote monitoring and specialist review as essential parts of cardiovascular care, and support funding arrangements that keep those services available across Australia.
Campaign for Patient Access